Dr. Luis Pérez de Sevilla is a neuroscientist focused on retinal biology, neurodegeneration, and the cellular and molecular mechanisms of neurological disease. His work uses genetic models, electrophysiology, and advanced imaging to investigate disease pathology and potential therapeutic targets.
His career includes extensive research in Canada, Germany, and the USA, most recently at UCLA prior to joining Biocient, along with numerous peer-reviewed publications investigating retinal and neuronal function. At Biocient, Dr. Pérez de Sevilla leads scientific strategy and preclinical development efforts focused on mitochondrial biology and neurodegenerative disease.

Ward Schacht is a legal executive with more than 20 years of experience advising organizations on corporate strategy, commercial transactions, regulatory compliance, risk management, intellectual property, and corporate governance, including within highly regulated industries. Over the course of his career, Ward has served as General Counsel and a trusted strategic advisor to executive leadership, leading complex commercial transactions, governance and compliance initiatives, litigation strategy, and intellectual property matters. His experience includes negotiating high-value agreements, managing enterprise legal risk, developing corporate policies, and helping organizations navigate complex business, regulatory, and operational challenges.